Product Information
MEROPENEM IV 500 MG VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.8678 per EA under NDC 00143943010. Its NADAC has been published 7 times since Feb 5, 2025.
Strength
500 mg/20mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143943010
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Last Updated
2/5/2025
Active Ingredients
MEROPENEMApproval Type
Generic (ANDA)
FDA Application
ANDA216424On Market Since
9/1/2024
Pharmacological Classes
Price Statistics
The NADAC for MEROPENEM IV 500 MG VIAL has been published 7 times since Feb 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8678 per EA |
|---|---|
| All-time high | $2.8678 (Mar 19, 2025) |
| All-time low | $2.8678 (Feb 5, 2025) |
| Median price | $2.8678 |
| Average price | $2.8678 |
| Largest weekly change | 0.0% (Feb 12, 2025) |
| Weeks tracked | 7 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEROPENEM IV 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 500 MG VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.8678 per EA (NDC 00143943010), effective Mar 19, 2025.
How has the price of MEROPENEM IV 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for MEROPENEM IV 500 MG VIAL has held within roughly two percent of its current level. It has been tracked across 7 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for MEROPENEM IV 500 MG VIAL?
Since Feb 5, 2025, the NADAC for MEROPENEM IV 500 MG VIAL has ranged from a low of $2.8678 (Feb 5, 2025) to a high of $2.8678 (Mar 19, 2025), with a median of $2.8678 per EA.
Are there cheaper alternatives to MEROPENEM IV 500 MG VIAL?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MEROPENEM IV 500 MG VIAL, but none are currently priced below it.
Who manufactures MEROPENEM IV 500 MG VIAL?
MEROPENEM IV 500 MG VIAL (NDC 00143943010) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification